RxDoctor Payments Data

Michael Navato

Psychiatry · Independence, MONPI 1235337668

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $67,050 of the $79,630 with a category attached, or 84.2%. 18 manufacturers reported payments, led by Alkermes, Inc. at 58.6% of the total. Reporting peaked in 2019 at $37,774 and has fallen 51.4% since, to $18,369 in 2021. Among psychiatry clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,630in general payments, 2019–2025

Across 317 payments — averaging $251.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$47K
  • Teva Pharmaceuticals USA, Inc.$31K
  • Johnson & Johnson$437
  • Vanda Pharmaceuticals Inc.$373
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$369
  • Sunovion Pharmaceuticals Inc.$312
  • plus $894 from 12 others

What the payments were for

  • Speaking & faculty fees$67,05084%
  • Travel & lodging$7,3739%
  • Food & beverage$5,0486%
  • Education$1580%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,630 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Other psychiatry in Independence

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →